Cycloalkyl piperidine tachykinin receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/08 (2006.01) A61K 31/451 (2006.01) A61K 31/454 (2006.01) A61K 31/506 (2006.01) C07D 211/46 (2006.01) C07D 401/14 (2006.01)

Patent

CA 2586972

The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.

L'invention concerne certains composés pipéridine utiles en tant qu'antagonistes du récepteur de la neurokinine 1 (NK-1), et des inhibiteurs de tachykinine et en particulier de substance P. L'invention concerne également des formulations pharmaceutiques comprenant ces composés utilisés en tant qu'ingrédients actifs et l'utilisation desdits composés et de leurs formulations dans le traitement de certains troubles, notamment les vomissements, l'incontinence urinaire, la dépression, et l'anxiété.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cycloalkyl piperidine tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cycloalkyl piperidine tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl piperidine tachykinin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1887209

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.